Oakbrook Investments LLC boosted its holdings in shares of CVS Health Corp (NYSE:CVS) by 51.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,371 shares of the pharmacy operator’s stock after purchasing an additional 2,500 shares during the period. Oakbrook Investments LLC’s holdings in CVS Health were worth $599,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. State Treasurer State of Michigan lifted its position in shares of CVS Health by 16.7% in the 3rd quarter. State Treasurer State of Michigan now owns 2,349,640 shares of the pharmacy operator’s stock valued at $191,073,000 after acquiring an additional 336,200 shares in the last quarter. Taylor Cottrill Erickson & Associates Inc. lifted its position in shares of CVS Health by 10.6% in the 3rd quarter. Taylor Cottrill Erickson & Associates Inc. now owns 8,367 shares of the pharmacy operator’s stock valued at $680,000 after acquiring an additional 800 shares in the last quarter. Butensky & Cohen Financial Security Inc. lifted its position in shares of CVS Health by 12.3% in the 3rd quarter. Butensky & Cohen Financial Security Inc. now owns 24,022 shares of the pharmacy operator’s stock valued at $1,953,000 after acquiring an additional 2,630 shares in the last quarter. Meeder Asset Management Inc. lifted its position in shares of CVS Health by 18,755.0% in the 3rd quarter. Meeder Asset Management Inc. now owns 18,855 shares of the pharmacy operator’s stock valued at $1,533,000 after acquiring an additional 18,755 shares in the last quarter. Finally, Fisher Asset Management LLC lifted its position in shares of CVS Health by 0.5% in the 3rd quarter. Fisher Asset Management LLC now owns 261,022 shares of the pharmacy operator’s stock valued at $21,226,000 after acquiring an additional 1,344 shares in the last quarter. 81.63% of the stock is owned by institutional investors and hedge funds.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the transaction, the executive vice president now owns 43,178 shares in the company, valued at approximately $3,504,758.26. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.61% of the company’s stock.

Several brokerages recently commented on CVS. Royal Bank of Canada began coverage on shares of CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target for the company. Jefferies Group upped their price target on shares of CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Needham & Company LLC restated a “hold” rating on shares of CVS Health in a research report on Sunday, September 10th. Oppenheimer reiterated a “buy” rating and issued a $95.00 price objective on shares of CVS Health in a research note on Monday, October 9th. Finally, Mizuho set a $90.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $86.35.

CVS Health Corp (CVS) opened at $73.56 on Thursday. The firm has a market cap of $73,249.45, a P/E ratio of 12.66, a price-to-earnings-growth ratio of 1.36 and a beta of 0.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. During the same quarter in the prior year, the business posted $1.64 EPS. CVS Health’s quarterly revenue was up 3.5% on a year-over-year basis. equities research analysts expect that CVS Health Corp will post 5.9 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Oakbrook Investments LLC Acquires 2,500 Shares of CVS Health Corp (CVS)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/12/21/oakbrook-investments-llc-acquires-2500-shares-of-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.